Sort
48,018 grants matching “immunotherapy”
Developmental Funds
$828,396Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2021 · CA
Developmental Funds
$828,396Ben H Park · Vanderbilt University Medical Center · P30 · FY2023 · CA
Developmental Funds
$828,350Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2020 · CA
Shared Resource: Comparative Medicine
$828,315Gordon Roble · Fred Hutchinson Cancer Center · P30 · FY2024 · CA
Shared Resource: Comparative Medicine
$828,313Gordon Roble · Fred Hutchinson Cancer Center · P30 · FY2023 · CA
Shared Resource: Comparative Medicine
$828,313Gordon Roble · Fred Hutchinson Cancer Center · P30 · FY2022 · CA
Allogeneic glioma vaccine using TGF-beta knockouts
$828,132Habib Fakhrai · Novarx Corporation · R44 · FY2009 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$828,114Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · CA
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$827,495Aimee S Payne · University Of Pennsylvania · R01 · FY2022 · AR
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$827,495Aimee S Payne · University Of Pennsylvania · R01 · FY2021 · AR
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
$827,457R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Role of Tumor Stroma in Therapeutic Response and Resistance
$827,411Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish
$827,215Leanna J Standish · Bastyr University · U19 · FY2012 · AT
Mechanobiology
$827,166Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2025 · EB
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$827,143Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2020 · DE
MicroSPECT/CT to aid the development of theranostics
$827,060Zhenghong Lee · Case Western Reserve University · S10 · FY2024 · OD
Targeting cancer neoantigens in patients with myeloid malignancies
$826,515Vid Leko · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeting PD-1 Pathway for Functional Cure of AIDS
$826,489Rama Rao Amara · Emory University · R37 · FY2022 · AI
ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME
$826,451Michael S Rafii · University Of California, San Diego · R01 · FY2014 · AG
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$826,420Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2021 · CA
Developing new immunotherapies based of CD4 T cells
$826,167Nicholas Restifo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$826,095Leslie S Kean · Emory University · R01 · FY2011 · HL
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center
$825,857Alan David Hutson · Roswell Park Cancer Institute Corp · U24 · FY2025 · CA
Immune epigenetic biomarkers of survival in glioma epidemiology
$825,775John K. Wiencke · University Of California, San Francisco · R01 · FY2017 · CA
Regulatory dendritic cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$825,391Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI